# Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset

> **NCT07094763** · NA · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of University of Science and Technology of China** · enrollment: 406 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** TNK plus standard medical treatment
- **DRUG:** standard medical management

## Key facts

- **NCT ID:** NCT07094763
- **Lead sponsor:** The First Affiliated Hospital of University of Science and Technology of China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-05
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 406 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07094763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07094763, "Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07094763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*